175 related articles for article (PubMed ID: 9677455)
21. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
[TBL] [Abstract][Full Text] [Related]
22. Prognostic role of p27Kip1 and apoptosis in human breast cancer.
Wu J; Shen ZZ; Lu JS; Jiang M; Han QX; Fontana JA; Barsky SH; Shao ZM
Br J Cancer; 1999 Mar; 79(9-10):1572-8. PubMed ID: 10188908
[TBL] [Abstract][Full Text] [Related]
23. Reciprocal expression of Bcl-2 and p53 in breast ductal carcinoma.
Lee WY; Jin YT; Tzeng CC
Anticancer Res; 1996; 16(5A):3007-12. PubMed ID: 8917421
[TBL] [Abstract][Full Text] [Related]
24. Bcl2, p53 and clinical outcome in a series of 138 operable breast cancer patients.
Castiglione F; Sarotto I; Fontana V; Destefanis M; Venturino A; Ferro S; Cardaropoli S; Orengo MA; Porcile G
Anticancer Res; 1999; 19(5C):4555-63. PubMed ID: 10650810
[TBL] [Abstract][Full Text] [Related]
25. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases.
Olopade OI; Adeyanju MO; Safa AR; Hagos F; Mick R; Thompson CB; Recant WM
Cancer J Sci Am; 1997; 3(4):230-7. PubMed ID: 9263629
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of bcl-2 oncoprotein expression in stage II colon carcinoma.
Sinicrope FA; Hart J; Michelassi F; Lee JJ
Clin Cancer Res; 1995 Oct; 1(10):1103-10. PubMed ID: 9815900
[TBL] [Abstract][Full Text] [Related]
28. Image cytometric bcl-2:bax and bcl-2:bcl-x ratios in invasive breast carcinoma: correlation with prognosis.
Schiller AB; Clark WS; Cotsonis G; Lawson D; DeRose PB; Cohen C
Cytometry; 2002 Aug; 50(4):203-9. PubMed ID: 12210599
[TBL] [Abstract][Full Text] [Related]
29. Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy.
Gasparini G; Bevilacqua P; Bonoldi E; Testolin A; Galassi A; Verderio P; Boracchi P; Guglielmi RB; Pezzella F
Clin Cancer Res; 1995 Nov; 1(11):1375-83. PubMed ID: 9815934
[TBL] [Abstract][Full Text] [Related]
30. Measures of cell turnover (proliferation and apoptosis) and their association with survival in breast cancer.
Liu S; Edgerton SM; Moore DH; Thor AD
Clin Cancer Res; 2001 Jun; 7(6):1716-23. PubMed ID: 11410511
[TBL] [Abstract][Full Text] [Related]
31. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung.
Shabnam MS; Srinivasan R; Wali A; Majumdar S; Joshi K; Behera D
Lung Cancer; 2004 Aug; 45(2):181-8. PubMed ID: 15246189
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of Bak expression in oral tongue squamous cell carcinomas.
Xie X; Clausen OP; Boysen M
Oncol Rep; 2003; 10(2):369-74. PubMed ID: 12579274
[TBL] [Abstract][Full Text] [Related]
33. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
[TBL] [Abstract][Full Text] [Related]
34. Correlation of Bcl-2 and p53 expression in primary breast tumors and corresponding metastatic lymph nodes.
Arun B; Kilic G; Yen C; Foster B; Yardley D; Gaynor R; Ashfaq R
Cancer; 2003 Dec; 98(12):2554-9. PubMed ID: 14669273
[TBL] [Abstract][Full Text] [Related]
35. Extent, relationship and prognostic significance of apoptosis and cell proliferation in synovial sarcoma.
Sun B; Sun Y; Wang J; Zhao X; Wang X; Hao X
Eur J Cancer Prev; 2006 Jun; 15(3):258-65. PubMed ID: 16679870
[TBL] [Abstract][Full Text] [Related]
36. Apoptosis suppressing protein bcl-2 is expressed in well-differentiated breast carcinomas with favourable prognosis.
Lipponen P; Pietiläinen T; Kosma VM; Aaltomaa S; Eskelinen M; Syrjänen K
J Pathol; 1995 Sep; 177(1):49-55. PubMed ID: 7472779
[TBL] [Abstract][Full Text] [Related]
37. Bcl-2 protein expression and long-term survival in breast cancer.
Joensuu H; Pylkkänen L; Toikkanen S
Am J Pathol; 1994 Nov; 145(5):1191-8. PubMed ID: 7977649
[TBL] [Abstract][Full Text] [Related]
38. Expression of p53 protein has no independent prognostic value in breast cancer.
Pietiläinen T; Lipponen P; Aaltomaa S; Eskelinen M; Kosma VM; Syrjänen K
J Pathol; 1995 Nov; 177(3):225-32. PubMed ID: 8551383
[TBL] [Abstract][Full Text] [Related]
39. In vivo patterns of Bcl-2 family protein expression in breast carcinomas in relation to apoptosis.
Rochaix P; Krajewski S; Reed JC; Bonnet F; Voigt JJ; Brousset P
J Pathol; 1999 Mar; 187(4):410-5. PubMed ID: 10398099
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer.
Kawasaki H; Altieri DC; Lu CD; Toyoda M; Tenjo T; Tanigawa N
Cancer Res; 1998 Nov; 58(22):5071-4. PubMed ID: 9823313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]